Compare BioNTech SE - ADR (BNTX) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Lufax Holding Ltd — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Lufax Holding Ltd trades at $1.56 (market cap $2.41B). The key difference: BioNTech SE - ADR is far larger — about 9.7× Lufax Holding Ltd's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| BNTX | LU | |
|---|---|---|
Market Cap | $23.31B | $2.41B |
Sector | Health | Technology |
52-Week High | $119.34 | $4.40 |
52-Week Low | $83.89 | $1.23 |
Enterprise Value | $6.60B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
